A Case of Cystoid Macular Edema Associated with Paclitaxel Chemotherapy.
10.3341/kjo.2012.26.5.388
- Author:
Dong Sik HAM
1
;
Joo Eun LEE
;
Hyun Woong KIM
;
Il Han YUN
Author Information
1. Department of Ophthalmology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. maekbak@hanmail.net
- Publication Type:Case Reports
- Keywords:
Macular edema;
Paclitaxel
- MeSH:
Adenocarcinoma/drug therapy;
Antineoplastic Agents, Phytogenic/*adverse effects;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use;
Humans;
Lung Neoplasms/drug therapy;
Macular Edema/*chemically induced;
Male;
Middle Aged;
Paclitaxel/*adverse effects;
Remission, Spontaneous;
Tomography, Optical Coherence;
Visual Acuity
- From:Korean Journal of Ophthalmology
2012;26(5):388-390
- CountryRepublic of Korea
- Language:English
-
Abstract:
We encountered a patient with cystoid macular edema (CME) secondary to paclitaxel use. A 57-year-old man presented with gradual decreased bilateral vision. His chemotherapeutic regimen consisted of bevacizumab, paclitaxel (175 mg/m2 for 5 months), and carboplatin. Optical coherence tomography imaging revealed bilateral CME greater than 500 microm. However, one year later, visual acuity was improved, best-corrected Snellen visual acuity was 40 / 80 in each eye, and CME was spontaneously improved. Our study confirmed that macular edema associated with paclitaxel use shows spontaneous resolution and improvement of visual acuity after a change of chemotherapeutic regimen.
